Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 35951-36000 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT07116785
Accelerated Rotational Field Deep TMS for Treating OCD
NARecruiting
50 participants
Started: Sep 19, 2023 · Completed: Dec 14, 2028
1 condition2 sponsors1 location
NCT05992688
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
NARecruiting
210 participants
Started: Sep 19, 2023 · Completed: Nov 30, 2026
4 conditions2 sponsors2 locations
NCT06102109
Long-term Results of Two Surgical Methods for Scleral IOL Implantation and Fixation in Eyes Without Capsular Support: Yamane- Versus 4-flanged Technique
NARecruiting
100 participants
Started: Sep 19, 2023 · Completed: Sep 30, 2028
4 conditions1 sponsor1 location
NCT05989880
Pilot Feasibility Trial of the SafeLM Supraglottic Airway (SGA)
NARecruiting
60 participants
Started: Sep 19, 2023 · Completed: Dec 2, 2025
1 condition1 sponsor1 location
NCT05860894
Post Intensive Care Unit Atrial Fibrillation
NARecruiting
150 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05668234
Study of the Parent's Subjective Experience of Parent-child Psychotherapy.
N/ARecruiting
20 participants
Started: Sep 19, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05816850
Multilayer Biological Characterization of Advanced Follicular Lymphoma: a Translational Study From FIL_FOLL12 Trial
N/ARecruiting
654 participants
Started: Sep 19, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor26 locations
NCT05722769
CSTOP Now! Child Sex Trafficking Stops With You
NARecruiting
5,408 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06351007
Educational Program on Dietary Adherence and Nutritional Knowledge in Chronic Kidney Disease Patients (EPAK)
NARecruiting
63 participants
Started: Sep 19, 2023 · Completed: Jul 31, 2024
7 conditions1 sponsor1 location
NCT05987020
Effects of Aromatherapy for Older Adults at Risk of Metabolic Syndrome in the Community
NARecruiting
64 participants
Started: Sep 19, 2023 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT06099145
Clinical and Medico-economic Validation of the HEPHAI Solution.
NARecruiting
238 participants
Started: Sep 19, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor5 locations
NCT05758701
CT TAVR Abdomen Study
PHASE4Recruiting
164 participants
Started: Sep 19, 2023 · Completed: Mar 1, 2027
1 condition1 sponsor1 location
NCT06100991
CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
N/ARecruiting
200 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2099
1 condition1 sponsor1 location
NCT06096324
Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)
NARecruiting
500 participants
Started: Sep 19, 2023 · Completed: Mar 31, 2027
3 conditions2 sponsors1 location
NCT05872347
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
PHASE2Recruiting
52 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor25 locations
NCT05935540
ACP-Family Programme for Palliative Care Patients and Their Family Member
NARecruiting
170 participants
Started: Sep 19, 2023 · Completed: Nov 30, 2025
1 condition3 sponsors3 locations
NCT06195917
Robotic-assisted Percutaneous Transhepatic Puncture
NARecruiting
20 participants
Started: Sep 19, 2023 · Completed: May 1, 2024
1 condition1 sponsor1 location
NCT05975606
Non-invasive Brain Stimulation Paired With FES Cycling Post SCI
NARecruiting
14 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06140160
Anterior Thoracic Perforating Artery (PATA); Systematization and Applications in Reconstructive Surgery of the Head and Neck
NARecruiting
75 participants
Started: Sep 19, 2023 · Completed: Sep 19, 2024
3 conditions2 sponsors1 location
NCT05909683
Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODIFY Trial)
PHASE3Recruiting
190 participants
Started: Sep 19, 2023 · Completed: Dec 27, 2026
1 condition1 sponsor15 locations
NCT06465979
Perception of Speech in Context by Listeners With Healthy and Impaired Hearing
NARecruiting
680 participants
Started: Sep 19, 2023 · Completed: Aug 31, 2027
2 conditions2 sponsors2 locations
NCT06163833
Mesenchymal Stromal Cells for Traumatic Brain Injury
PHASE2Recruiting
78 participants
Started: Sep 19, 2023 · Completed: Dec 31, 2026
1 condition4 sponsors3 locations
NCT05939674
Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam
NARecruiting
24 participants
Started: Sep 19, 2023 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT05699005
Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO
PHASE1Recruiting
238 participants
Started: Sep 18, 2023 · Completed: Dec 18, 2025
5 conditions7 sponsors1 location
NCT05787119
Benefit of Augmented Reality Mirror Therapy in Addition to Conventional Management in Complex Regional Pain Syndrome of the Upper Extremity
NARecruiting
7 participants
Started: Sep 18, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06051292
Decremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement
NARecruiting
27 participants
Started: Sep 18, 2023 · Completed: Dec 30, 2025
3 conditions1 sponsor4 locations
NCT06052150
Oral Health In Cirrhosis of the Liver (ORACLE)
N/ARecruiting
100 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors2 locations
NCT05789940
Hysteroscopy vs. Endouterine Aspiration in the Management of Trophoblastic Retention
NARecruiting
220 participants
Started: Sep 18, 2023 · Completed: Jan 1, 2029
1 condition1 sponsor4 locations
NCT06133673
KSS Autism: Parameters and Future Care
N/ARecruiting
30 participants
Started: Sep 18, 2023 · Completed: Sep 18, 2024
3 conditions1 sponsor1 location
NCT05916300
Diagnostic Ultrasonography in Physiotherapy
N/ARecruiting
70 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT05932134
High Protein, Core Muscle Rehab, Muscular Electrostimulation in Prolonged Mechanical Ventilation
NARecruiting
100 participants
Started: Sep 18, 2023 · Completed: Mar 21, 2025
2 conditions1 sponsor1 location
NCT04972071
SW-RCT Implementation of Canadian Syncope Risk Score Based Practice Recommendations
NARecruiting
14,400 participants
Started: Sep 18, 2023 · Completed: Mar 1, 2026
1 condition1 sponsor15 locations
NCT05092022
St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic
NARecruiting
50 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05828628
CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study
N/ARecruiting
36 participants
Started: Sep 18, 2023 · Completed: Sep 30, 2031
1 condition1 sponsor1 location
NCT05937672
Cold Atmospheric Plasma Device Extension Study
PHASE3Recruiting
40 participants
Started: Sep 18, 2023 · Completed: Feb 1, 2026
2 conditions2 sponsors1 location
NCT06215456
Virtual Reality to Reduce Periprocedural Anxiety During Invasive Coronary Angiography
NARecruiting
100 participants
Started: Sep 18, 2023 · Completed: Apr 30, 2024
2 conditions1 sponsor1 location
NCT05812963
IVUS Versus FFR for Non-infarct Related Artery Lesions in Patients With Multivessel Disease and Acute MI
NARecruiting
1,400 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2029
2 conditions2 sponsors2 locations
NCT05966961
Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
N/ARecruiting
2,998 participants
Started: Sep 18, 2023 · Completed: Aug 31, 2028
1 condition2 sponsors4 locations
NCT05854303
Effect of Opioid Cessation on Opioid-Induced Esophageal Dysfunction
N/ARecruiting
26 participants
Started: Sep 18, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT05681468
Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources
NARecruiting
175 participants
Started: Sep 18, 2023 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT05288790
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
PHASE2Recruiting
250 participants
Started: Sep 18, 2023 · Completed: Feb 28, 2027
5 conditions3 sponsors1 location
NCT06236594
Application of Multimodal Endoscopic Functional Imaging Technology in the Diagnosis of Common Gastrointestinal Diseases
N/ARecruiting
100 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06001333
Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract
NARecruiting
240 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors2 locations
NCT06034327
Efficacy in Controlling Myopia in Young Children Using a Novel Spectacle Lens
NARecruiting
150 participants
Started: Sep 18, 2023 · Completed: Mar 31, 2026
3 conditions1 sponsor14 locations
NCT06756321
A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy
EARLY_PHASE1Recruiting
9 participants
Started: Sep 18, 2023 · Completed: Mar 18, 2026
2 conditions2 sponsors1 location
NCT05998447
GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer
PHASE2Recruiting
148 participants
Started: Sep 18, 2023 · Completed: Oct 31, 2026
1 condition2 sponsors6 locations
NCT05706402
N-acetylcysteine (NAC) for the Treatment of Acute Exacerbation of COPD
PHASE3Recruiting
80 participants
Started: Sep 18, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06001593
Modulating Auditory Symptoms and Vertigo of Meniere's Disease by Non-invasive Mastoid Electric Stimulation
PHASE1/PHASE2Recruiting
120 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06133595
Mi Bridge - Motivational Interviewing to Facilitate Help-seeking Among Individuals with Sexual Interest in Children
NARecruiting
60 participants
Started: Sep 18, 2023 · Completed: Oct 8, 2024
2 conditions8 sponsors6 locations
NCT06047080
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
PHASE3Recruiting
1,130 participants
Started: Sep 18, 2023 · Completed: Dec 31, 2030
1 condition1 sponsor274 locations